Owner SYNERGY PHARMACEUTICALS, INC.

Inventors SHAILUBHAI, Kunwar; NIKIFOROVICH, Gregory; JACOB, Gary, S.

Pub. Number AU-A-2002252527

PCT Pub. Number WO2002/078683

Priority 60/348,646 17.01.02 US; 60/279,438 29.03.01 US; 60/279,437 29.03.01 US; 60/300,850 27.06.01 US; 60/303,806 10.07.01 US; 60/307,358 25.07.01 US

Filing date 28 March 2002

Wipo publication date 15 October 2002

A61K 031/00

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/48 Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

G01N 033/567 Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

G01N 033/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

A61K 038/00 Medicinal preparations containing peptides

A01N 061/00 Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action

C12Q 001/00 Measuring or testing processes involving enzymes or micro-organisms

C07K 002/00 Peptides of undefined number of amino acids

C07K 004/00 Peptides having up to 20 amino acids in an undefined or only partially defined sequence

C07K 005/00 Peptides having up to four amino acids in a fully defined sequence

C07K 007/00 Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 014/00 Peptides having more than 20 amino acids

C07K 016/00 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 017/00 Carrier-bound or immobilised peptides